Rhythm Pharmaceuticals Inc Long-term Investment Intensity
Rhythm Pharmaceuticals Inc long-term investment intensity. Rhythm Pharmaceuticals Inc (RYTM) has a Long-term Investment Intensity of 5.0% as of June 2023. Long-term investments of $15.52 Million represent 5.0% of total assets of $309.94 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Rhythm Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Rhythm Pharmaceuticals Inc (2015–2022)
Long-term investment intensity of Rhythm Pharmaceuticals Inc from 2015 to 2022. This chart shows how Rhythm Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2022. As of June 2023, the intensity stands at 5.0%, reflecting long-term investments of $15.52 Million against total assets of $309.94 Million USD. See Rhythm Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Rhythm Pharmaceuticals Inc Long-term Investment Intensity by Year (2015–2022)
Rhythm Pharmaceuticals Inc long-term investment intensity by year from 2015 to 2022. The table below presents the year-by-year Long-term Investment Intensity for Rhythm Pharmaceuticals Inc from 2015 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see RYTM current and non-current assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 4.4% | $16.66 Million | $382.48 Million | ▲ +0.8 pp |
| 2021 | 3.6% | $11.81 Million | $329.52 Million | ▲ +3.4 pp |
| 2015 | 0.2% | $60.00K | $37.27 Million | — |